UNSPSC 51111857: Lasofoxifene

This classification denotes a selective estrogen receptor modulator with the molecular formula C28H31NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 337G83N988, chemically known as 2-naphthalenol, 5,6,7,8-tetrahydro-6-phenyl-5-(4-(2-(1-pyrrolidinyl)ethoxy)phenyl)-, (5r-cis)- but generally known as lasofoxifene, which bears US NIH Compound Identifier 216416. European Medicines Agency schedules Lasofoxifene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB27754.

UNSPSC 51111857 Lasofoxifene is a Commodity code for a selective estrogen receptor modulator (SERM) pharmaceutical used in the treatment of postmenopausal osteoporosis. The source provides no record of recent state and local contract opportunities under this code. State and local procurement activity in pharmaceutical commodities at this level of specificity is rare; purchasing of individual drug formulations typically occurs through healthcare agencies, state Medicaid programs, and institutional buyers (hospitals, clinics, correctional health systems) as part of broader vendor agreements, formulary listings, or group purchasing contracts negotiated at higher organizational levels rather than through standalone solicitations tagged to specific drug codes.

Without documented recent opportunities, no geographic concentration, issuing-body patterns, or representative solicitations can be characterized from current market activity.